Dr. Gregory Krastein, MD

Dr. Krastein practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Krastein's NPI, 1942358759, was assigned on January 8, 2007. Dr. Krastein graduated from George Washington University School of Medicine and Health Sciences in 1989. Dr. Krastein holds California license G70211.

Dr. Krastein's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Krastein's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Krastein is also affiliated with Kaiser Permanente Moanalua Medical Center. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Dr. Krastein to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Krastein practices, 2 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Krastein's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Krastein is board certified in nephrology by the American Board of Internal Medicine. Dmand AI has Dr. Krastein's licenses on file in 2 states: California and Hawaii.

Dmand AI lists acute kidney failure, chronic hypertension, chronic kidney disease, essential tremor, fluid and electrolyte imbalances, lower back pain, parathyroid gland disorder and tobacco use among the conditions Dr. Krastein treats.

CMS data shows 56 Medicare services from Dr. Krastein across 2 procedure codes in 2024, all of them office visits, for 46 Medicare patients. Medicare paid $3,568 for them. Every service was in an office.

CMS counts 46 Medicare patients who saw Dr. Krastein in 2024. The largest group is 75 to 84, with 14 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 54% are also on Medicaid. Their average risk score is 3.38, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Krastein's median patient age at 65, with 46% women.

In 2024, Dr. Krastein wrote 1,205 Medicare Part D claims for 287 patients. 89% of them were for generic drugs. CMS names the drug for 1,039 of them, across 22 drugs with 11 or more claims each, at $85,973 in total drug cost. In 2023, CMS named 1,133 claims across 23 drugs.

Dr. Krastein accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Krastein as offering telehealth.

CMS Open Payments shows 15 general payments to Dr. Krastein from 9 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 100% of the total. Relypsa, Inc. paid the most, $125.

Dmand AI lists 1 award for Dr. Krastein, most recently CMS Stage 1 2012 in 2011.

Dr. Krastein graduated from George Washington University School of Medicine and Health Sciences in 1989.

Dr. Krastein is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Kaiser Permanente. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.